Continuous deterioration in subacute sclerosing panencephalitis during treatment with isoprinosine and intrathecal interferon alpha

I. Korn-Lubetzki; S. Revei-Vilk; I. Steiner; Y. Shoshan; H. Hurvitz

Continuous deterioration in subacute sclerosing panencephalitis during treatment with isoprinosine and intrathecal interferon alpha

I. Korn-Lubetzki^*, S. Revei-Vilk, I. Steiner, Y. Shoshan, H. Hurvitz

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract

Combined treatment with oral isoprinosine and intrathecal interferon alpha is considered to be the treatment of choice in subacute sclerosing panencephalitis (SSPE). We report the case of a 13-year-old SSPE patient who deteriorated over a 17-month period despite the early and continuous recommended treatment.

Original language	English
Pages (from-to)	163-165
Number of pages	3
Journal	Neurological Infections and Epidemology
Volume	2
Issue number	3
State	Published - 1997
Externally published	Yes

Keywords

Interferon
Isoprinosine
Subacute slerosing panencephalitis
Treatment

Cite this

@article{5dea60042c704cc1a129e7662100a31c,

title = "Continuous deterioration in subacute sclerosing panencephalitis during treatment with isoprinosine and intrathecal interferon alpha",

abstract = "Combined treatment with oral isoprinosine and intrathecal interferon alpha is considered to be the treatment of choice in subacute sclerosing panencephalitis (SSPE). We report the case of a 13-year-old SSPE patient who deteriorated over a 17-month period despite the early and continuous recommended treatment.",

keywords = "Interferon, Isoprinosine, Subacute slerosing panencephalitis, Treatment",

author = "I. Korn-Lubetzki and S. Revei-Vilk and I. Steiner and Y. Shoshan and H. Hurvitz",

year = "1997",

language = "אנגלית",

volume = "2",

pages = "163--165",

journal = "Neurological Infections and Epidemology",

issn = "1084-4759",

number = "3",

}

TY - JOUR

T1 - Continuous deterioration in subacute sclerosing panencephalitis during treatment with isoprinosine and intrathecal interferon alpha

AU - Korn-Lubetzki, I.

AU - Revei-Vilk, S.

AU - Steiner, I.

AU - Shoshan, Y.

AU - Hurvitz, H.

PY - 1997

Y1 - 1997

N2 - Combined treatment with oral isoprinosine and intrathecal interferon alpha is considered to be the treatment of choice in subacute sclerosing panencephalitis (SSPE). We report the case of a 13-year-old SSPE patient who deteriorated over a 17-month period despite the early and continuous recommended treatment.

AB - Combined treatment with oral isoprinosine and intrathecal interferon alpha is considered to be the treatment of choice in subacute sclerosing panencephalitis (SSPE). We report the case of a 13-year-old SSPE patient who deteriorated over a 17-month period despite the early and continuous recommended treatment.

KW - Interferon

KW - Isoprinosine

KW - Subacute slerosing panencephalitis

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=0030803662&partnerID=8YFLogxK

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

AN - SCOPUS:0030803662

SN - 1084-4759

VL - 2

SP - 163

EP - 165

JO - Neurological Infections and Epidemology

JF - Neurological Infections and Epidemology

IS - 3

ER -

Continuous deterioration in subacute sclerosing panencephalitis during treatment with isoprinosine and intrathecal interferon alpha

Abstract

Keywords

Other files and links

Fingerprint

Cite this